Ali S. Haider

Ali S. Haider

Auto-generated profile, based on publicly available information

Ali S. Haider

Rice University, Houston, United States

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2019 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
AHAndrew T Hale
Andrew T Hale
SSSonali Sen
Sonali Sen
AHAli S Haider
Ali S Haider
FPFreedom F Perkins
Freedom F Perkins
DCDave F Clarke
Dave F Clarke
LTLuke D Tomycz
Luke D Tomycz
BACKGROUND: Various studies suggest that the insular cortex may play an underappreciated role in pediatric frontotemporal/parietal epilepsy. Here, we report on the postsurgical outcomes in 26 pediatric patients with confirmed insular involvement by depth electrode monitoring. OBJECTIVE: To describe one of the largest series of pediatric patients with medically refractory epilepsy undergoing laser interstitial thermal therapy (LITT) or surgical resection of at least some portion of the insular cortex. METHODS: Pediatric patients in whom invasive insular sampling confirmed insular involvement and who subsequently underwent a second stage surgery (LITT or open resection) were included. Complications and Engel Class outcomes at least 1 yr postsurgery were compiled as well as pathology results in the open surgical cases. RESULTS: The average age in our cohort was 10.3 yr, 58% were male, and the average length of follow-up was 2.43 ± 0.20 (SEM) yr. A total of 14 patients underwent LITT, whereas 12 patients underwent open resection. Complications in patients undergoing either LITT or open resection were mostly minimal and generally transient. Forty-three percent of patients who underwent LITT were Engel Class I, compared to 50% of patients who underwent open insular resection. CONCLUSION: Both surgical resection and LITT are valid management options in the treatment of medically refractory insular/opercular epilepsy in children. Although LITT may be a less invasive alternative to craniotomy, further studies are needed to determine its noninferiority in terms of complication rates and seizure freedom, especially in cases of cortical dysplasia that may involve extensive regions of the brain.

26 November 2021 in Cancers
Verified
Journal Article
Open access
PDF file
PPPaolo Palmisciano
Paolo Palmisciano
AHAli S. Haider
Ali S. Haider
MSMohammadmahdi Sabahi
Mohammadmahdi Sabahi
CNChibueze D. Nwagwu
Chibueze D. Nwagwu
OBOthman Bin-Alamer
Othman Bin-Alamer
OPOmar Pathmanaban
Omar Pathmanaban
Background: Primary skull base chondrosarcomas (SBCs) can severely affect patients’ quality of life. Surgical-resection and radiotherapy are feasible but may cause debilitating complications. We systematically reviewed the literature on primary SBCs. Methods: PubMed, EMBASE, Scopus, Web-of-Science, and Cochrane were searched following the PRISMA guidelines to include studies of patients with primary SBCs. Clinical characteristics, management strategies, and treatment outcomes were analyzed. Results: We included 33 studies comprising 1307 patients. Primary SBCs mostly involved the middle-fossa (72.7%), infiltrating the cavernous-sinus in 42.4% of patients. Cranial-neuropathies were reported in 810 patients (62%). Surgical-resection (93.3%) was preferred over biopsy (6.6%). The most frequent open surgical approaches were frontotemporal-orbitozygomatic (17.6%) and pterional (11.9%), and 111 patients (21.3%) underwent endoscopic-endonasal resection. Post-surgical cerebrospinal-fluid leaks occurred in 36 patients (6.5%). Radiotherapy was delivered in 1018 patients (77.9%): photon-based (41.4%), proton-based (64.2%), and carbon-based (13.1%). Severe post-radiotherapy complications, mostly hypopituitarism (15.4%) and hearing loss (7.1%) were experienced by 251 patients (30.7%). Post-treatment symptom-improvement (46.7%) and reduced/stable tumor volumes (85.4%) showed no differences based on radiotherapy-protocols (p = 0.165; p = 0.062). Median follow-up was 67-months (range, 0.1–376). SBCs recurrences were reported in 211 cases (16.1%). The 5-year and 10-year progression-free survival rates were 84.3% and 67.4%, and overall survival rates were 94% and 84%. Conclusion: Surgical-resection and radiotherapy are effective treatments in primary SBCs, with acceptable complication rates and favorable local tumor control.

7 December 2019 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
AHAli S Haider
Ali S Haider
MBMartin van Den Bent
Martin van Den Bent
PWPatrick Y Wen
Patrick Y Wen
MVMichael A Vogelbaum
Michael A Vogelbaum
SCSusan Chang
Susan Chang
JHJason Thomas Huse
Jason Thomas Huse
Regardless of subtype, diffuse gliomas of adulthood are characterized by inexorable progression through treatment. Cancer recurrence in the context of therapy is by no means unique to gliomas. For many tumors residing outside the central nervous system (CNS), tissue-based analyses are routinely employed to document the molecular and cellular features of disease recurrence. Such interventions are inconsistently applied for gliomas, however, and lack rigorous standardization when they are. While many of the reasons underlying these discrepancies reflect pragmatic realities inherent to CNS disease, the suboptimal employment of histological and molecular assessment at recurrence nevertheless represents a missed opportunity to proactively guide patient management and increase knowledge. Herein, we address this quandary by pairing a succinct description of the histological, biological, and molecular characteristics of recurrent glioma with recommendations for how to better standardize and implement quality pathological assessment into patient management. We hope this review will prompt thoughtful revision of standard operating procedures to maximize the utility of glioma re-biopsy.

3 July 2021 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PPPaolo Palmisciano
Paolo Palmisciano
AHAli S. Haider
Ali S. Haider
CNChibueze D. Nwagwu
Chibueze D. Nwagwu
WWWaseem Wahood
Waseem Wahood
SASalah G. Aoun
Salah G. Aoun
TATarek Y. El Ahmadieh
Tarek Y. El Ahmadieh

19 November 2021 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
PPPaolo Palmisciano
Paolo Palmisciano
TATarek Y. El Ahmadieh
Tarek Y. El Ahmadieh
AHAli S. Haider
Ali S. Haider
OAOthman Bin Alamer
Othman Bin Alamer
FRFaith C. Robertson
Faith C. Robertson
RSRaymond Sawaya
Raymond Sawaya

31 March 2023 in Neurospine
Verified
Journal Article
Open access
PDF file
CAChristopher Alvarez-Breckenridge
Christopher Alvarez-Breckenridge
RARomulo Augusto Andrade de Almeida
Romulo Augusto Andrade de Almeida
AHAli Haider
Ali Haider
MMMatthew Muir
Matthew Muir
JBJustin Bird
Justin Bird
CTClaudio E. Tatsui
Claudio E. Tatsui
Purpose: Carbon-fiber reinforced polyetheretherketone (CFRP)-based spinal implants are an alternative to titanium, offering less image artifact as their metallic counterparts while maintaining similar biomechanical and biocompatibility properties. Its use in the management of spinal tumors has been reported, however the perceived advantages related to improved imaging quality, radiation treatment planning, and detection of tumor recurrence have not been fully assessed.Methods: We performed a retrospective review of medical records amongst oncologic patients treated at MD Anderson Cancer Center with CFRP implants. Histology, tumor location, construct features, time of follow-up, adjuvant radiation, recurrences, overall survival, and hardware-related complications were recorded.Results: Sixty-nine consecutive patients were assessed (22 primary tumors, 47 metastases) and the median time for follow-up was 5.4 months. Amongst the cohort, a total of 491 CFRP pedicle screws were implanted. Hardware complications were observed in 5 cases (7.04%). Adjuvant radiation was completed in 8 patients with primary tumors and 29 patients with spinal metastases. A total of 28 patients (40.5%) from the combined primary and metastatic cohorts experienced systemic disease progression, with 12 patients (17.3%) demonstrating local recurrences. Amongst primary and metastatic tumors, overall survival (p = 0.363) and rate of local recurrence (p = 0.112) were similar.Conclusion: This largest series of CFRP implants demonstrates safe and effective spinal stabilization for patients with both primary and metastatic tumors. Enhanced postoperative imaging led to minimal imaging artifacts which facilitated postoperative radiation planning and the ability to detect local recurrence.